Furthermore, this case provides rationale for repetitive genomic analysis in treatment resistant EMPD lesions and contributes to the growing evidence of ERBB2 in the pathogenesis of metastatic extramammary Paget’s disease. The gene discussed is ERBB2; the disease is extramammary Paget disease.